Welcome to Cochlear ProNews, your source for professional news that allows you to stay up to date on the latest research and hot topics in the hearing industry. Content includes surgical insights, clinical conversations, AudiologyOnline opportunities and peer-to-peer material. Also, don’t miss out on important information about our services and products such as the Nucleus® 8, Kanso® 2, Baha® 6 Max and Osia® Sound Processors. Subscribe now!

Featured posts

A Deeper Dive into Nucleus® SmartNav Intraoperative Testing

Intraoperative testing using tools such as Nucleus® SmartNav may provide surgeons and audiologists valuable real-time insights regarding the surgery, device function, and neural response to stimulation. The operating room (OR) is also a unique environment that requires quick decision-making and interpretation of the information available to the surgical team. This article will help provide surgeons and audiologists a better understanding of Placement […]

Read More

Counseling on Cochlear™ Electrodes

At Cochlear, we believe that technology is at the center of what gives each patient the opportunity to reach their full potential in hearing and in life. Cochlear is committed to partnering with you to understand and support your expertise to deliver the best possible care for your patients. One important aspect of a cochlear implant that can have a significant impact […]

Read More

Cochlear receives FDA clearance to lower the age for the Osia® System to 5 years old

Lone Tree, Colo. (April 19, 2024) – Cochlear Limited (ASX: COH), the global leader in implantable hearing solutions, obtained U.S. Food and Drug Administration (FDA) clearance to lower the age of the Cochlear™  Osia System from 12 years-old to 5 years-old for children with conductive hearing loss, mixed hearing loss and single-sided sensorineural deafness (SSD). The Osia System is a new category […]

Read More

All posts